Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | SLC9A1 | P19634 | 4/20 | 0.42 |
| ▸ | SLC9A2 | Q9UBY0 | 4/20 | 0.42 |
| ▸ | SLC9A3 | P48764 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7682913 | 0.85 | SRD5A1 (0.38) | L3MBTL1TDP1 | |
| SCHEMBL7685298 | 0.82 | L3MBTL1 (0.45) | L3MBTL1 | |
| SCHEMBL12958096 | 0.79 | SLC9A1 (0.45) | L3MBTL1SLC9A1SLC9A2SLC9A3HTR7 | |
| SCHEMBL7689625 | 0.77 | L3MBTL1 (0.47) | L3MBTL1TDP1 | |
| SCHEMBL6794592 | 0.76 | SLC9A1 (0.43) | L3MBTL1SLC9A1SLC9A2SLC9A3HTR7 | |
| SCHEMBL7560076 | 0.75 | L3MBTL1 (0.36) | L3MBTL1SLC9A1SLC9A2SLC9A3TDP1 | |
| SCHEMBL10034989 | 0.71 | OPRL1 (0.44) | SLC9A1SLC9A2SLC9A3 | |
| SCHEMBL7683121 | 0.71 | ALDH1A1 (0.60) | L3MBTL1TDP1 | |
| SCHEMBL7690082 | 0.71 | POLB (0.36) | L3MBTL1TDP1 | |
| SCHEMBL11830644 | 0.70 | PTGDR2 (0.38) | SLC9A1SLC9A2SLC9A3HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1229019-A1 | PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE CYCLIC ENAMINONE DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2002-08-07 | — | — | EP | claimed |
| US-6706732-B1 | PROPHYLACTIC AND THERAPEUTIC EFFECT ON MYOCARDIAL INFARCTION AND ACCOMPANYING DYSFUNCTIONS, ARRHYTHMIA, UNSTABLE ANGINA, CARDIAC HYPERTROPHY, ETC.; SODIUM-PROTON EXCHANGE INHIBITION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2004-03-16 | — | — | US | disclosed |
| EP-1229019-A1 | PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE CYCLIC ENAMINONE DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2002-08-07 | — | — | EP | disclosed |
| EP-1182194-A1 | PERNASAL PREPARATIONS | Takeda Chemical Industries, Ltd. (JP) | 2002-02-27 | — | — | EP | disclosed |
| US-6350749-B1 | SODIUM CHANNEL MODULATORS, ANTIARRHYTHMIA AND HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS, ANGINA PECTORIS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-02-26 | — | — | US | disclosed |
| EP-1057812-A1 | AMINOGUANIDINE HYDRAZONE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND DRUGS THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2000-12-06 | — | — | EP | disclosed |
| EP-0950418-A2 | Composition for preventing or treating ischemic disease | Takeda Chemical Industries, Ltd. (JP) | 1999-10-20 | — | — | EP | disclosed |